期刊文献+

2,2′-二硒并烟酸及其叔丁基酯的合成和结构 被引量:1

Synthesis and Structures of 2,2′-Diselenobisnicotinic Acid and Its Tert-Butyl Ester
下载PDF
导出
摘要 本文以2-氯烟酸为原料合成了2,2′-二硒并烟酸叔丁基酯(1)及2,2′-二硒并烟酸(2),化合物1和2的结构分别用1H NMR,13CNMR,77Se NMR,元素分析和X-射线单晶结构测定技术进行了表征。在化合物1和2的晶体结构中,吡啶环和2个硒原子处于同一平面,这一结果与已报道的芳基二硒醚化合物的晶体结构完全不同。 2,2'-diselenobisnicotinic acid tert-butyl ester (1) and 2,2'-diselenobisnicotinic acid (2) were synthesized based on 2-ehloronieotinic acid. Compounds 1 and 2 were well characterized by ^1H NMR, ^13C NMR, ^77Se NMR, elemental analysis and X-ray single crystal structural analyses. The crystal structure of compound 1 belongs to triclinic crystal system and P1 space group, and the crystal structure of compound 2 is monoclinic crystal system and P21/c space group. In the crystal structure of 1 or 2, the two selenium atoms and two pyridyls are coplanar, which is very different from the reported crystal structures of diaromatic diselelenide. CCDC: 729953, 1; 729952, 2.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2009年第6期1073-1076,共4页 Chinese Journal of Inorganic Chemistry
基金 国家自然科学基金(No.20572065) 山西省自然科学基金(No.2008011021 No.2008012013-2) 山西省回国留学基金资助项目
关键词 2 2'-二硒并烟酸 2 2'-二硒并烟酸叔丁酯 晶体结构 2,2'-diselenobisnicotinic acid 2,2'-diselenobisnicotinic acid tea-butyl ester crystal structure
  • 相关文献

参考文献11

  • 1Back T G.Organoselenium Chemistrys-A Practical Approach.Oxford:Oxford University Press,1999.
  • 2Mugesh G,Wolf-Wahher M,Sies H.Chem.Rev.,2001,101:2130-2179
  • 3Mugesh G,Singh H B.Chem.Soc.Rev.,2000,29:350-357
  • 4Mugesh G,Bhabak K P.Chem.Eur.J.,2008,14:8640-8651
  • 5Hao P,Peter J S,Sergey G.Chem.Mater.,2007,19:301-307
  • 6Braga A L,Vargas F,Sehnem J A,et al.J.Org.Chem.,2005,70:9021-9024
  • 7Bhasin K K,Singh J.J.Organomet.Chem.,2002,658:71-76
  • 8Duran M L,Romero J,et al.Inorg.Chim.Acta,1997,255:307-311
  • 9Kienitz C O,Thone C,Jones P G.Inorg.Chem.,1996,35:3990-3997
  • 10Kienitz C O,Thone C,Jones P G.Z.Naturfforsch.,Teil B,2000,55:587-596

同被引文献16

  • 1冉宇,刘君玲,张强.他汀类和烟酸类降脂药物联合应用治疗心血管疾病[J].中国心血管杂志,2007,12(1):78-80. 被引量:2
  • 2王宗明 何欣翔 孙殿卿.实用红外光谱学[M].北京:石油工业出版社,1990..
  • 3KAJINAM I K, TAKEKOSHI N. Cholesterol absorption inhibitors in development as potential theropentics [ J ]. Expert Opin Inest Drugs, 2002, 11(6) :831 -835.
  • 4PRESCOTY D L, MAZZ A, SUN J X, et al. Rosuvastat in provides superior benefits in lipid therapy [ J ]. Inphama, 2003, 1282:4 - 6.
  • 5VACCARI C S,HAMMOUD R A, NAQAMIA S H, et al. Revisiting niacin : reviewing the evidence [ J ]. J Clin Lipidol, 2007, 1 ( 4 ) : 248 - 255.
  • 6SPIVEY K S, TITGEMEYER E C, BRADFORD B J. Pharmacologi- cal amounts of nicotinic acid can reduce isoproterenol - stimulated lipolysis in cattle, but also reduce feed intake [ J ]. J Anim Sci, 2009, 87:252 -256.
  • 7BONDESSON G, HEDBOM C, MAGNUSSON O. Pontential hypo- lipidemic agents. X. plasma lipid - lowering properties of some ali- phatic amino alcohols [ J ]. Acta Pharm Suec, 1974, 11 ( 5 ) :417 - 426.
  • 8ZHANG X J, ZHU J, XIONG X Y, et al. Synthesis of resveratrol and resveratrol trinincotinate[ J]. J Chin Pharm Sci, 2004, 13 (1) : 10 -12.
  • 9王建国.葡萄糖-阿司匹林共价复合物的合成及体外释放研究[D].赣州:赣南师范学院,2009.
  • 10刘耀武,金传山.DMAP催化合成白藜芦醇烟酸酯[J].宿州学院学报,2010,25(2):39-41. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部